Showing results (341-350 of 996) with videos related to
Sort By:
Pageof 100
Cancer Investigation|January 1, 1983
Study of the natural history of immunoblastic lymphadenopathy and atypical immunoproliferative disordersG Lopez-Berestein, F Cabanillas, B M Osborne, et al.American Journal of Clinical Oncology|October 1, 1982
Phase II clinical evaluation of AZQ in colorectal cancerA Y Bedikian, J R Stroehlein, D A Karlin, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1991
In vitro activity of cefpodoxime against bacterial isolates obtained from patients with cancerK V Rolston, M Messer, H Nguyen, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1986
Imipenem/cilastatin as secondary therapy for infections in cancer patientsG P Bodey, K Rolston, P Jones, et al.Antimicrobial Agents and Chemotherapy|November 1, 1990
In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patientsK V Rolston, H Nguyen, M Messer, et al.Cancer|July 11, 1998
How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?I I Raad, D Abi-Said, K V Rolston, et al.Antimicrobial Agents and Chemotherapy|September 1, 1984
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patientsL Jadeja, R Bolivar, V Fainstein, et al.Blood|August 1, 1982
Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adultsS S Legha, M J Keating, K B McCredie, et al.Journal of Medicine|January 1, 1980
Comparative distribution of Baker's antifolate (NSC 139105) in rat tissues after subcutaneous and intravenous injectionsB C Yang, D H Ho, N S Brown, et al.Journal of Surgical Oncology|January 1, 1981
Combination therapy for advanced malignant melanoma with BCNU, pseudomonas vaccine, and heparinR D Snyder, G N Hortobagyi, G P Bodey, et al.Pageof 100